These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18422337)

  • 1. Subattomole sensitivity in biological accelerator mass spectrometry.
    Salehpour M; Possnert G; Bryhni H
    Anal Chem; 2008 May; 80(10):3515-21. PubMed ID: 18422337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerator mass spectrometry of small biological samples.
    Salehpour M; Forsgard N; Possnert G
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3928-34. PubMed ID: 18980253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological accelerator mass spectrometry at Uppsala University.
    Salehpour M; Possnert G; Bryhni H; Palminger-Hallén I; Ståhle L
    Appl Radiat Isot; 2009 Mar; 67(3):495-9. PubMed ID: 18789710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FemtoMolar measurements using accelerator mass spectrometry.
    Salehpour M; Forsgard N; Possnert G
    Rapid Commun Mass Spectrom; 2009 Mar; 23(5):557-63. PubMed ID: 19177507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studies.
    Minamimoto R; Hamabe Y; Miyaoka T; Hara T; Yoshida K; Oka T; Inoue T
    Ann Nucl Med; 2008 Dec; 22(10):883-9. PubMed ID: 19142707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a 250 kV single-stage accelerator mass spectrometer with a 5 MV tandem accelerator mass spectrometer--fitness for purpose in bioanalysis.
    Young GC; Corless S; Felgate CC; Colthup PV
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4035-42. PubMed ID: 19009519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
    Barker J; Garner RC
    Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitating isotopic molecular labels with accelerator mass spectrometry.
    Vogel JS; Love AH
    Methods Enzymol; 2005; 402():402-22. PubMed ID: 16401517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
    Chung IM; Kim SH
    Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of beryllium in biological samples by accelerator mass spectrometry: applications for studying chronic beryllium disease.
    Chiarappa-Zucca ML; Finkel RC; Martinelli RE; McAninch JE; Nelson DO; Turteltaub KW
    Chem Res Toxicol; 2004 Dec; 17(12):1614-20. PubMed ID: 15606137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals.
    Salehpour M; Ekblom J; Sabetsky V; Håkansson K; Possnert G
    Rapid Commun Mass Spectrom; 2010 May; 24(10):1481-9. PubMed ID: 20411588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerator mass spectrometry.
    Hellborg R; Skog G
    Mass Spectrom Rev; 2008; 27(5):398-427. PubMed ID: 18470926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerator mass spectrometry best practices for accuracy and precision in bioanalytical (14)C measurements.
    Vogel JS; Giacomo JA; Schulze-König T; Keck BD; Lohstroh P; Dueker S
    Bioanalysis; 2010 Mar; 2(3):455-68. PubMed ID: 21083255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerator mass spectrometry for biomedical research.
    Brown K; Dingley KH; Turteltaub KW
    Methods Enzymol; 2005; 402():423-43. PubMed ID: 16401518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible incorporation of petroleum-based carbons in biochemicals produced by bioprocess--biomass carbon ratio measured by accelerator mass spectrometry.
    Kunioka M
    Appl Microbiol Biotechnol; 2010 Jun; 87(2):491-7. PubMed ID: 20454790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
    Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
    Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of accelerator mass spectrometry for pharmacological and toxicological research.
    Brown K; Tompkins EM; White IN
    Mass Spectrom Rev; 2006; 25(1):127-45. PubMed ID: 16059873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated combustion accelerator mass spectrometry for the analysis of biomedical samples in the low attomole range.
    van Duijn E; Sandman H; Grossouw D; Mocking JA; Coulier L; Vaes WH
    Anal Chem; 2014 Aug; 86(15):7635-41. PubMed ID: 25033319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interface for direct analysis of (14)c in nonvolatile samples by accelerator mass spectrometry.
    Liberman RG; Tannenbaum SR; Hughey BJ; Shefer RE; Klinkowstein RE; Prakash C; Harriman SP; Skipper PL
    Anal Chem; 2004 Jan; 76(2):328-34. PubMed ID: 14719879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein.
    Lappin G; Garner RC; Meyers T; Powell J; Varley P
    J Pharm Biomed Anal; 2006 Jun; 41(4):1299-302. PubMed ID: 16554138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.